12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements during Wednesday's after-market session. Nexalin Technology, Tempest Therapeutics, ASLAN Pharma, Talphera, Geovax Labs, and SAB Biotherapeutics saw notable gains, while Biolase, Castle Biosciences, Mustang Bio, Evaxion Biotech, Soligenix, and BIMI Holdings experienced declines.
June 19, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ASLAN Pharma's stock increased by 18.51% to $0.37, raising its market cap to $8.3 million.
The notable price increase indicates positive investor sentiment or favorable news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Geovax Labs' stock increased by 13.15% to $2.15, raising its market cap to $5.4 million.
The price increase indicates positive investor sentiment or favorable news.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Nexalin Technology's stock surged by 48.1% to $1.54, increasing its market cap to $11.4 million.
The significant price increase indicates strong investor interest or positive news related to the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SAB Biotherapeutics' stock rose by 8.94% to $2.8, with a market cap of $25.8 million.
The price increase suggests positive investor sentiment or favorable developments.
CONFIDENCE 65
IMPORTANCE 55
RELEVANCE 100
POSITIVE IMPACT
Talphera's stock rose by 15.18% to $0.9, with a market cap of $15.2 million.
The price increase suggests positive investor sentiment or favorable developments.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Tempest Therapeutics' stock rose by 40.0% to $3.99, with a market cap of $88.6 million.
The substantial price increase suggests positive developments or strong investor sentiment.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
BIMI Holdings' stock declined by 7.41% to $1.25, reducing its market cap to $17.4 million.
The price decrease suggests negative investor sentiment or unfavorable developments.
CONFIDENCE 65
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
Biolase's stock fell by 15.5% to $0.11, decreasing its market cap to $3.6 million.
The significant price decrease indicates negative investor sentiment or unfavorable news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Castle Biosciences' stock declined by 10.77% to $19.82, reducing its market cap to $547.1 million.
The notable price decrease suggests negative investor sentiment or unfavorable developments.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Evaxion Biotech's stock decreased by 9.53% to $2.47, reducing its market cap to $13.3 million.
The notable price decrease suggests negative investor sentiment or unfavorable developments.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Mustang Bio's stock fell by 10.59% to $0.76, decreasing its market cap to $21.4 million.
The significant price decrease indicates negative investor sentiment or unfavorable news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Soligenix's stock declined by 8.5% to $3.88, decreasing its market cap to $3.8 million.
The price decrease indicates negative investor sentiment or unfavorable news.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100